ID   Q99AU2_9HEPC            Unreviewed;      3010 AA.
AC   Q99AU2;
DT   01-JUN-2001, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2001, sequence version 1.
DT   24-JUN-2015, entry version 116.
DE   RecName: Full=Genome polyprotein {ECO:0000256|RuleBase:RU000330, ECO:0000256|SAAS:SAAS00058068};
OS   Hepatitis C virus subtype 1b.
OC   Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage;
OC   Flaviviridae; Hepacivirus.
OX   NCBI_TaxID=31647 {ECO:0000313|EMBL:AAK08509.1};
RN   [1] {ECO:0000313|PIR:PQ0246}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=1658209;
RA   Oshima M., Tsuchiya M., Yagasaki M., Orita T., Hasegawa M.,
RA   Tomonoh K., Kojima T., Hirata Y., Yamamoto O., Sho Y.;
RT   "cDNA clones of Japanese hepatitis C virus genomes derived from a
RT   single patient show sequence heterogeneity.";
RL   J. Gen. Virol. 72:2805-2809(1991).
RN   [2] {ECO:0000313|PIR:PQ0804}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=8385694;
RA   Simmonds P., McOmish F., Yap P.L., Chan S.W., Lin C.K., Dusheiko G.,
RA   Saeed A.A., Holmes E.C.;
RT   "Sequence variability in the 5' non-coding region of hepatitis C
RT   virus: identification of a new virus type and restrictions on sequence
RT   diversity.";
RL   J. Gen. Virol. 74:661-668(1993).
RN   [3] {ECO:0000313|EMBL:AAK08509.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=chimera of HCV-BK {ECO:0000313|EMBL:AAK08509.1};
RX   PubMed=11677216;
RA   Thomson M., Nascimbeni M., Gonzales S., Murthy K.K., Rehermann B.,
RA   Liang T.J.;
RT   "Emergence of a distinct pattern of viral mutations in chimpanzees
RT   infected with a homogeneous inoculum of hepatitis C virus.";
RL   Gastroenterology 121:1226-1233(2001).
RN   [4] {ECO:0000213|PDB:2HAI}
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 2420-2989, DISULFIDE BONDS,
RP   AND AND SULFINATION AT CYS-2642.
RX   PubMed=16824756; DOI=10.1016/j.bmcl.2006.06.065;
RA   Li H., Tatlock J., Linton A., Gonzalez J., Borchardt A., Dragovich P.,
RA   Jewell T., Prins T., Zhou R., Blazel J., Parge H., Love R., Hickey M.,
RA   Doan C., Shi S., Duggal R., Lewis C., Fuhrman S.;
RT   "Identification and structure-based optimization of novel
RT   dihydropyrones as potent HCV RNA polymerase inhibitors.";
RL   Bioorg. Med. Chem. Lett. 16:4834-4838(2006).
RN   [5] {ECO:0000213|PDB:2FVC}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2420-2982.
RX   PubMed=16451063; DOI=10.1021/jm050855s;
RA   Tedesco R., Shaw A.N., Bambal R., Chai D., Concha N.O., Darcy M.G.,
RA   Dhanak D., Fitch D.M., Gates A., Gerhardt W.G., Halegoua D.L., Han C.,
RA   Hofmann G.A., Johnston V.K., Kaura A.C., Liu N., Keenan R.M.,
RA   Lin-Goerke J., Sarisky R.T., Wiggall K.J., Zimmerman M.N., Duffy K.J.;
RT   "3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-
RT   quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA
RT   polymerase.";
RL   J. Med. Chem. 49:971-983(2006).
RN   [6] {ECO:0000213|PDB:2GC8}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2420-2989.
RX   PubMed=16722622; DOI=10.1021/jm060168g;
RA   Gopalsamy A., Chopra R., Lim K., Ciszewski G., Shi M., Curran K.J.,
RA   Sukits S.F., Svenson K., Bard J., Ellingboe J.W., Agarwal A.,
RA   Krishnamurthy G., Howe A.Y., Orlowski M., Feld B., O'Connell J.,
RA   Mansour T.S.;
RT   "Discovery of proline sulfonamides as potent and selective hepatitis C
RT   virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase
RT   binding site.";
RL   J. Med. Chem. 49:3052-3055(2006).
RN   [7] {ECO:0000213|PDB:2D3U, ECO:0000213|PDB:2D3Z, ECO:0000213|PDB:2D41}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 2420-2989, AND DISULFIDE
RP   BONDS.
RX   PubMed=16828488; DOI=10.1016/j.jmb.2006.05.074;
RA   Biswal B.K., Wang M., Cherney M.M., Chan L., Yannopoulos C.G.,
RA   Bilimoria D., Bedard J., James M.N.;
RT   "Non-nucleoside inhibitors binding to hepatitis C virus NS5B
RT   polymerase reveal a novel mechanism of inhibition.";
RL   J. Mol. Biol. 361:33-45(2006).
RN   [8] {ECO:0000213|PDB:2IJN}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2422-2989.
RX   PubMed=17049853; DOI=10.1016/j.bmcl.2006.10.002;
RA   Yan S., Appleby T., Gunic E., Shim J.H., Tasu T., Kim H., Rong F.,
RA   Chen H., Hamatake R., Wu J.Z., Hong Z., Yao N.;
RT   "Isothiazoles as active-site inhibitors of HCV NS5B polymerase.";
RL   Bioorg. Med. Chem. Lett. 17:28-33(2007).
RN   [9] {ECO:0000213|PDB:2QE2, ECO:0000213|PDB:2QE5}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 2420-2989, AND DISULFIDE
RP   BONDS.
RX   PubMed=17402724; DOI=10.1021/jm061428x;
RA   Nittoli T., Curran K., Insaf S., DiGrandi M., Orlowski M., Chopra R.,
RA   Agarwal A., Howe A.Y., Prashad A., Floyd M.B., Johnson B.,
RA   Sutherland A., Wheless K., Feld B., O'Connell J., Mansour T.S.,
RA   Bloom J.;
RT   "Identification of anthranilic acid derivatives as a novel class of
RT   allosteric inhibitors of hepatitis C NS5B polymerase.";
RL   J. Med. Chem. 50:2108-2116(2007).
RN   [10] {ECO:0000213|PDB:3HHK}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 2420-2982.
RX   PubMed=19515564; DOI=10.1016/j.bmcl.2009.05.091;
RA   Shaw A.N., Tedesco R., Bambal R., Chai D., Concha N.O., Darcy M.G.,
RA   Dhanak D., Duffy K.J., Fitch D.M., Gates A., Johnston V.K.,
RA   Keenan R.M., Lin-Goerke J., Liu N., Sarisky R.T., Wiggall K.J.,
RA   Zimmerman M.N.;
RT   "Substituted benzothiadizine inhibitors of Hepatitis C virus
RT   polymerase.";
RL   Bioorg. Med. Chem. Lett. 19:4350-4353(2009).
RN   [11] {ECO:0000213|PDB:3O8B, ECO:0000213|PDB:3O8C, ECO:0000213|PDB:3O8D}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 1029-1657 IN COMPLEX WITH
RP   ADP AND ZINC, AND DISULFIDE BONDS.
RX   PubMed=21145896; DOI=10.1016/j.jmb.2010.11.034;
RA   Appleby T.C., Anderson R., Fedorova O., Pyle A.M., Wang R., Liu X.,
RA   Brendza K.M., Somoza J.R.;
RT   "Visualizing ATP-dependent RNA translocation by the NS3 helicase from
RT   HCV.";
RL   J. Mol. Biol. 405:1139-1153(2011).
CC   -!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
CC       + RNA(n+1). {ECO:0000256|SAAS:SAAS00153520}.
CC   -!- SIMILARITY: Contains RdRp catalytic domain.
CC       {ECO:0000256|SAAS:SAAS00153546}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF333324; AAK08509.1; -; mRNA.
DR   PIR; A61196; A61196.
DR   PIR; PQ0246; PQ0246.
DR   PIR; PQ0804; PQ0804.
DR   PIR; PS0329; PS0329.
DR   PDB; 2D3U; X-ray; 2.00 A; A/B=2420-2989.
DR   PDB; 2D3Z; X-ray; 1.80 A; A/B=2420-2989.
DR   PDB; 2D41; X-ray; 2.10 A; A/B=2420-2989.
DR   PDB; 2FVC; X-ray; 2.00 A; A/B=2420-2982.
DR   PDB; 2GC8; X-ray; 2.20 A; A/B=2420-2989.
DR   PDB; 2HAI; X-ray; 1.58 A; A=2420-2989.
DR   PDB; 2IJN; X-ray; 2.20 A; A/B=2422-2989.
DR   PDB; 2QE2; X-ray; 2.90 A; A/B=2420-2989.
DR   PDB; 2QE5; X-ray; 2.60 A; A/B/C/D=2420-2989.
DR   PDB; 3HHK; X-ray; 1.70 A; A/B=2420-2982.
DR   PDB; 3O8B; X-ray; 1.95 A; A/B=1029-1657.
DR   PDB; 3O8C; X-ray; 2.00 A; A/B=1029-1657.
DR   PDB; 3O8D; X-ray; 2.05 A; A/B=1029-1657.
DR   PDB; 3O8R; X-ray; 2.30 A; A/B=1029-1657.
DR   PDBsum; 2D3U; -.
DR   PDBsum; 2D3Z; -.
DR   PDBsum; 2D41; -.
DR   PDBsum; 2FVC; -.
DR   PDBsum; 2GC8; -.
DR   PDBsum; 2HAI; -.
DR   PDBsum; 2IJN; -.
DR   PDBsum; 2QE2; -.
DR   PDBsum; 2QE5; -.
DR   PDBsum; 3HHK; -.
DR   PDBsum; 3O8B; -.
DR   PDBsum; 3O8C; -.
DR   PDBsum; 3O8D; -.
DR   PDBsum; 3O8R; -.
DR   ProteinModelPortal; Q99AU2; -.
DR   SMR; Q99AU2; 2-45, 902-1026, 1029-1657, 1973-2003, 2008-2170, 2420-2982.
DR   euHCVdb; AF333324; -.
DR   EvolutionaryTrace; Q99AU2; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019031; C:viral envelope; IEA:UniProtKB-KW.
DR   GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003968; F:RNA-directed RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0019087; P:transformation of host cell by virus; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR011492; DEAD_Flavivir.
DR   InterPro; IPR002521; HCV_core_C.
DR   InterPro; IPR002522; HCV_core_N.
DR   InterPro; IPR002519; HCV_env.
DR   InterPro; IPR002531; HCV_NS1.
DR   InterPro; IPR002518; HCV_NS2.
DR   InterPro; IPR000745; HCV_NS4a.
DR   InterPro; IPR001490; HCV_NS4b.
DR   InterPro; IPR002868; HCV_NS5a.
DR   InterPro; IPR013193; HCV_NS5a_1B_dom.
DR   InterPro; IPR024350; HCV_NS5a_C.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR013192; NS5A_1a.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR004109; Peptidase_S29.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR002166; RNA_pol_HCV.
DR   InterPro; IPR009003; Trypsin-like_Pept_dom.
DR   Pfam; PF07652; Flavi_DEAD; 1.
DR   Pfam; PF01543; HCV_capsid; 1.
DR   Pfam; PF01542; HCV_core; 1.
DR   Pfam; PF01539; HCV_env; 1.
DR   Pfam; PF01560; HCV_NS1; 1.
DR   Pfam; PF01538; HCV_NS2; 1.
DR   Pfam; PF01006; HCV_NS4a; 1.
DR   Pfam; PF01001; HCV_NS4b; 1.
DR   Pfam; PF01506; HCV_NS5a; 1.
DR   Pfam; PF08300; HCV_NS5a_1a; 1.
DR   Pfam; PF08301; HCV_NS5a_1b; 1.
DR   Pfam; PF12941; HCV_NS5a_C; 1.
DR   Pfam; PF02907; Peptidase_S29; 1.
DR   Pfam; PF00998; RdRP_3; 1.
DR   ProDom; PD001388; HCV_env; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS51693; HCV_NS2_PRO; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS50507; RDRP_SSRNA_POS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding {ECO:0000256|SAAS:SAAS00058020};
KW   Capsid protein {ECO:0000256|RuleBase:RU000330,
KW   ECO:0000256|SAAS:SAAS00057850};
KW   Glycoprotein {ECO:0000256|RuleBase:RU000330};
KW   Helicase {ECO:0000256|SAAS:SAAS00058020};
KW   Host-virus interaction {ECO:0000256|RuleBase:RU000330};
KW   Hydrolase {ECO:0000256|SAAS:SAAS00058020};
KW   Membrane {ECO:0000256|RuleBase:RU000330}; Metal-binding;
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00058020};
KW   Nucleotidyltransferase {ECO:0000256|SAAS:SAAS00153521};
KW   Ribonucleoprotein {ECO:0000256|RuleBase:RU000330};
KW   RNA-binding {ECO:0000256|RuleBase:RU000330};
KW   RNA-directed RNA polymerase {ECO:0000256|SAAS:SAAS00153521};
KW   Transferase {ECO:0000256|SAAS:SAAS00153521};
KW   Transmembrane {ECO:0000256|RuleBase:RU000330};
KW   Viral envelope protein {ECO:0000256|RuleBase:RU000330};
KW   Viral nucleoprotein {ECO:0000256|RuleBase:RU000330};
KW   Viral RNA replication {ECO:0000256|SAAS:SAAS00250960};
KW   Virion {ECO:0000256|RuleBase:RU000330, ECO:0000256|SAAS:SAAS00057850};
KW   Zinc {ECO:0000213|PDB:3O8B, ECO:0000213|PDB:3O8C}.
FT   NP_BIND    1233   1238       ADP. {ECO:0000213|PDB:3O8D,
FT                                ECO:0000213|PDB:3O8R}.
FT   METAL      1123   1123       Zinc.
FT   METAL      1125   1125       Zinc.
FT   METAL      1171   1171       Zinc.
FT   METAL      1175   1175       Zinc; via pros nitrogen.
FT                                {ECO:0000213|PDB:3O8C,
FT                                ECO:0000213|PDB:3O8R}.
FT   BINDING    1267   1267       ADP. {ECO:0000213|PDB:3O8D,
FT                                ECO:0000213|PDB:3O8R}.
FT   BINDING    1493   1493       ADP. {ECO:0000213|PDB:3O8D,
FT                                ECO:0000213|PDB:3O8R}.
FT   MOD_RES    2642   2642       Cysteine sulfinic acid (-SO2H).
FT                                {ECO:0000213|PDB:2HAI}.
FT   DISULFID   1123   1171       {ECO:0000213|PDB:3O8D}.
FT   DISULFID   2722   2730       {ECO:0000213|PDB:2D3U,
FT                                ECO:0000213|PDB:2D3Z,
FT                                ECO:0000213|PDB:2D41}.
SQ   SEQUENCE   3010 AA;  327011 MW;  053B9A653B0AB335 CRC64;
     MSTNPKPQRK TKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRATR KTSERSQPRG
     RRQPIPKARR PEGRTWAQPG YPWPLYGNEG MGWAGWLLSP RGSRPSWGPT DPRRRSRNLG
     KVIDTLTCGF ADLMGYIPLV GAPLGGAARA LAHGVRVLED GVNYATGNLP GCSFSIFLLA
     LLSCLTIPAS AYEVRNVSGI YHVTNDCSNS SIVYEAADMI MHTPGCVPCV RESNFSRCWV
     ALTPTLAARN SSIPTTTIRR HVDLLVGAAA LCSAMYVGDL CGSVFLVSQL FTFSPRRYET
     VQDCNCSIYP GHVSGHRMAW DMMMNWSPTT ALVVSQLLRI PQAVVDMVAG AHWGVLAGLA
     YYSMVGNWAK VLIVMLLFAG VDGHTHVTGG RVASSTQSLV SWLSQGPSQK IQLVNTNGSW
     HINRTALNCN DSLQTGFIAA LFYAHRFNAS GCPERMASCR PIDKFAQGWG PITHVVPNIS
     DQRPYCWHYA PQPCGIVPAS QVCGPVYCFT PSPVVVGTTD RSGVPTYSWG ENETDVLLLN
     NTRPPQGNWF GCTWMNSTGF TKTCGGPPCN IGGVGNNTLI CPTDCFRKHP EATYTKCGSG
     PWLTPRCLVD YPYRLWHYPC TINFTIFKVR MYVGGVEHRL NAACNWTRGE RCDLEDRDRS
     ELSPLLLSTT EWQVLPCSFT TLPALSTGLI HLHQNIVDVQ YLYGVGSVVV SVVIKWEYVL
     LLFLLLADAR VCACLWMMLL IAQAEATLEN LVVLNAASVA GAHGLLSFLV FFCAAWYIKG
     RLVPGAAYAL YGVWPLLLLL LALPPRAYAM DREMAASCGG AVFVGLVLLT LSPYYKVFLA
     RLIWWLQYFI TRAEAHLQVW VPPLNVRGGR DAIILLTCAV HPELIFDITK LLLAILGPLM
     VLQAGITRVP YFVRAQGLIH ACMLVRKVAG GHYVQMAFMK LGALTGTYIY NHLTPLRDWA
     HAGLRDLAVA VEPVVFSDME TKIITWGADT AACGDIILGL PVSARRGKEI LLGPADSLEG
     RGWRLLAPIT AYSQQTRGLL GCIITSLTGR DKNQVEGEVQ VVSTATQSFL ATCVNGVCWT
     VYHGAGSKTL AGPKGPITQM YTNVDQDLVG WQAPPGARSL TPCTCGSSDL YLVTRHADVI
     PVRRRGDSRG SLLSPRPVSY LKGSSGGPLL CPSGHAVGIF RAAVCTRGVA KAVDFVPVES
     METTMRSPVF TDNSSPPAVP QSFQVAHLHA PTGSGKSTKV PAAYAAQGYK VLVLNPSVAA
     TLGFGAYMSK AHGIDPNIRT GVRTITTGAP VTYSTYGKFL ADGGCSGGAY DIIICDECHS
     TDSTTILGIG TVLDQAETAG ARLVVLATAT PPGSVTVPHP NIEEVALSNT GEIPFYGKAI
     PIEAIRGGRH LIFCHSKKKC DELAAKLSGL GINAVAYYRG LDVSVIPTIG DVVVVATDAL
     MTGYTGDFDS VIDCNTCVTQ TVDFSLDPTF TIETTTVPQD AVSRSQRRGR TGRGRRGIYR
     FVTPGERPSG MFDSSVLCEC YDAGCAWYEL TPAETSVRLR AYLNTPGLPV CQDHLEFWES
     VFTGLTHIDA HFLSQTKQAG DNFPYLVAYQ ATVCARAQAP PPSWDQMWKC LIRLKPTLHG
     PTPLLYRLGA VQNEVTLTHP ITKYIMACMS ADLEVVTSTW VLVGGVLAAL AAYCLTTGSV
     VIVGRIILSG RPAIVPDREL LYQEFDEMEE CATHLPYIEQ GMQLAEQFKQ KALGLLQTAT
     KQAEAAAPVV ESKWRALETF WAKHMWNFIS GIQYLAGLST LPGNPAIASL MAFTASITSP
     LTTQSTLLFN ILGGWVAAQL APPSAASAFV GAGIAGAAVG SIGLGKVLVD ILAGYGAGVA
     GALVAFKVMS GEMPSTEDLV NLLPAILSPG ALVVGVVCAA ILRRHVGPGE GAVQWMNRLI
     AFASRGNHVS PTHYVPESDA AARVTQILSS LTITQLLKRL HQWINEDCST PCSGSWLRDV
     WDWICTVLTD FKTWLQSKLL PQLPGVPFFS CQRGYKGVWR GDGIMQTTCP CGAQITGHVK
     NGSMRIVGPK TCSNTWHGTF PINAYTTGPC TPSPAPNYSR ALWRVAAEEY VEVTRVGDFH
     YVTGMTTDNV KCPCQVPAPE FFSEVDGVRL HRYAPACRPL LREEVTFQVG LNQYLVGSQL
     PCEPEPDVAV LTSMLTDPSH ITAETAKRRL ARGSPPSLAS SSASQLSAPS LKATCTTHHV
     SPDADLIEAN LLWRQEMGGN ITRVESENKV VVLDSFDPLR AEEDEREVSV PAEILRKSKK
     FPAAMPIWAR PDYNPPLLES WKDPDYVPPV VHGCPLPPIK APPIPPPRRK RTVVLTESSV
     SSALAELATK TFGSSESSAV DSGTATALPD QASDDGDKGS DVESYSSMPP LEGEPGDPDL
     SDGSWSTVSE EASEDVVCCS MSYTWTGALI TPCAAEESKL PINALSNSLL RHHNMVYATT
     SRSAGLRQKK VTFDRLQVLD DHYRDVLKEM KAKASTVKAK LLSVEEACKL TPPHSAKSKF
     GYGAKDVRNL SSKAVNHIHS VWKDLLEDTV TPIDTTIMAK NEVFCVQPEK GGRKPARLIV
     FPDLGVRVCE KMALYDVVST LPQVVMGSSY GFQYSPGQRV EFLVNTWKSK KNPMGFSYDT
     RCFDSTVTEN DIRVEESIYQ CCDLAPEARQ AIKSLTERLY IGGPLTNSKG QNCGYRRCRA
     SGVLTTSCGN TLTCYLKASA ACRAAKLQDC TMLVNGDDLV VICESAGTQE DAASLRVFTE
     AMTRYSAPPG DPPQPEYDLE LITSCSSNVS VAHDASGKRV YYLTRDPTTP LARAAWETAR
     HTPVNSWLGN IIMYAPTLWA RMILMTHFFS ILLAQEQLEK ALDCQIYGAC YSIEPLDLPQ
     IIERLHGLSA FSLHSYSPGE INRVASCLRK LGVPPLRVWR HRARSVRARL LSQGGRAATC
     GKYLFNWAVK TKLKLTPIPA ASQLDLSGWF VAGYSGGDIY HSLSRARPRW FMLCLLLLSV
     GVGIYLLPNR
//
